Rubicon Research Gets One USFDA Observation; Shares Down
Shares of Rubicon Research were trading 1% lower on 12 October after the company received 1 observation from the US Food and Drug Administration (USFDA),...
Tag : US Food & Drug Administration (USFDA)
Lupin Gets Tentative USFDA Approval for Apixaban Oral Suspension
Lupin has received tentative approval from the US Food and Drug Administration (USFDA) for its New Drug Application for Apixaban Oral Suspension 1.25 mg/mL. The...
Alembic Pharma Gets USFDA Closure for Vadodara Facility
Shares of Alembic Pharmaceuticals Ltd soared 3% on September 17 after the US Food and Drug Administration (USFDA) closed its inspection of the company’s bioequivalence...
Aurobindo Pharma’s Unit IV Clears USFDA Inspection: Shares Down
Shares of Aurobindo Pharma Ltd were trading in the red and 1% lower on 15 September despite its wholly owned subsidiary, Apitoria Pharma, successfully completing...
Strides Pharma in Focus After USFDA Issues 3 Observations
Strides Pharma Science Ltd shares will remain in focus after the US Food and Drug Administration (USFDA) issued three observations following an inspection of the...
Aurobindo Pharma Gets Clean USFDA Inspection Report
Aurobindo Pharma announced that it has received a positive outcome from a US Food and Drug Administration (USFDA) inspection at its Andhra Pradesh facility. The...
Natco Pharma Facility Gets 4 USFDA Observations; Shares Up
Shares of Natco Pharma Ltd training higher after its Visakhapatnam-based finished dosage formulations facility received four observations from the US Food and Drug Administration (USFDA)....
Aurobindo Pharma Shares in Focus After USFDA Issues 1 Observation
Shares of Aurobindo Pharma were trading in the green and almost 1% higher on 24 August after the company received one observation from the US...
Dr Reddy’s Hyderabad Plant Receives 4 USFDA Observations; Shares Slump
Shares of Dr Reddy’s Laboratories Ltd were trading in the red and 1% lower on 17 August after its Bachupally, Hyderabad-based formulations manufacturing facility received...
Aurobindo Pharma in Focus After US FDA Warning Letter
Shares of Aurobindo Pharma Ltd slump 2% on 14 August after the US Food and Drug Administration (US FDA) issued a Warning Letter to Eugia...